SOE-dee-umFOSS -fate 
Contraindicated in:
Use Cautiously in:
Related to hyperphosphatemia, unless otherwise indicated
CNS: confusion, listlessness, weakness.
Resp: hypernatremia — shortness of breath.
CV: ARRHYTHMIAS, CARDIAC ARREST, ECG changes (absent P waves, widening of the QRS complex with biphasic curve), hypotension; hypernatremia — edema.
GI: diarrhea, abdominal pain, nausea, vomiting.
F and E: hyperkalemia, hypernatremia, hyperphosphatemia, hypocalcemia, hypomagnesemia.
Local: irritation at IV site, phlebitis.
MS: hypocalcemia — tremors.
Neuro: flaccid paralysis, heaviness of legs, paresthesias of extremities.
(Generic available)
Therapeutic Classification: mineral and electrolyte replacements/supplements
Pharmacologic Classification: phosphate supplements
Absorption: Administered IV only, resulting in complete bioavailability.
Distribution: Phosphates enter extracellular fluids and are then actively transported to sites of action.
Metabolism/Excretion: Excreted mainly (>90%) by the kidneys.
Half-life: Unknown.
NDC Code*